
Keywords: mAb; monoclonal antibody; BPD; benzoporphyrin derivative; PDT; photodynamic therapy; nanoPAL; nanophotoactivatable liposomes; PDAC; pancreatic ductal adenocarcinoma; VEGF; vascular endothelial growth factor; MAPK; mitogen activated protein kinases; HIF; h